+1.62%

S&O 500 5,382.45

-0.47%

US 10 400

+2.28%

Nasdaq 16,565.41

+2.28%

Crude Oil 16,565.41

-0.27%

FTSE 100 8,144.87

+1.06%

Gold 2,458.10

-0.53%

Euro 1.09

+0.36%

Pound/Dollar 1.27

Wednesday, November 4, 2026

Business News

New Data Demonstrated Best-in-Class Potential for Casdatifan, a HIF-2a Inhibitor, in Patients with Metastatic Kidney Cancer

by marketdash February 15, 2025

by marketdash February 15, 2025 0 comments

Get New Updates nto Take Care Your Pet

Discover the art of creating a joyful and nurturing environment for your beloved pet.

Will be used in accordance with our Privacy Policy

Most read

Earnings call transcript: Fraport’s q3 2026 results show stronger cash flow

November 4, 2026

Earnings call transcript: Zaptec posts record Q3 2026 revenue as margins improve

November 4, 2026

JPMorgan downgrades Crown Holdings stock rating on valuation

November 4, 2026

@ 2024 – Marketdash – All Rights Reserved.